SHOULD NUTRITIONAL PRODUCTS BE EVALUATED AND REIMBURSED IN THE SAME WAY PHARMACEUTICALS ARE? Issue Panel Session (IP25) 14 th November 2018
|
|
- Hubert Harris
- 5 years ago
- Views:
Transcription
1 SHOULD NUTRITIONAL PRODUCTS BE EVALUATED AND REIMBURSED IN THE SAME WAY PHARMACEUTICALS ARE? Issue Panel Session (IP25) 14 th November 2018
2 Outline Issue panel session Nutrition Economics Challenges & complexities Nutrition Economics Discrepancies in current reimbursement policies Dr. Karen Freijer Irene Lenoir-Wijnkoop Moreno Perugini Debate shared & opposing viewpoints All 2
3 Health Economics & Nutrition Economics Karen Freijer, PhD, BSc 14th November 2018 Chair ISPOR Nutrition Economics SIG
4 Disclosure Dept Health Services Research CAPHRI School for Public Health and Primary Care Founder & Chair Nutrition Economics Advisor Physician & (Nutrition) Lifestyle Education Commission Freijer4Food & health care Consultancy
5 Nutrition Economics Freijer K. Nutrition Economics: DRM & Economic value of medical nutrition-phdthesis 2014, Maastricht Univeristiy NL
6 Nutrition Economics Merging of nutrition and health economics discipline Interdependency between nutritional habits, health and public expenses To illustrate health and economic aspects of specific changes in the daily nutrition and nutrition recommendations through the lens of costeffectiveness Nutrition economics is defined as "a discipline dedicated to researching and characterizing health and economic outcomes in nutrition for the benefit of society 1 1. BJN 2011;105:
7 NUTRITION Difference healthy person - patient Healthy: death after approx. 70 days Ill: death after approx. 28 days Loss of muscle mass > 40% = death
8 NUTRITION Difference healthy person - patient Healthy: death after approx. 70 days Ill: death after approx. 28 days Loss of muscle mass > 40% = death
9 (Medical) Nutrition Novel synergistic combinations of nutrients Pharma (New) Chemical Entity (one compound) Nutrients focus on multiple fysiological systems, safety has been proven Focus on single intervention, adverse events
10 Health & Nutrition Overall population Conventional food Functional food Infant formula/food General nutrition Expert Meetings 1 & 2 British Journal of Nutrition 2011;105: British Journal of Nutrition 2013;108: Survival, energy, health, pleasure Targets specific body functions/risk factors Age specific needs Expert meeting 1 A rational exists for developing the field of Nutrition Economics, defined as a discipline dedicated to researching and characterising health and economic outcomes in nutrition for the benefit of society. Expert meeting 2 There is a need of up-to-date knowledge on the role of nutrition and to assess impacts for the individual, the healthcare system and society as a whole.
11 Health & Nutrition Overall population Diseased population (= patients) Medical nutrition Expert meeting 3 Specific characteristics of medical nutrition do need special attention: study design, study population, sample size, comparator, clinical research outcomes (endpoints) Enteral nutrition Parenteral nutrition Special enteral medical nutrition for all ages Special parenteral (intravenous) medical nutrition for all ages Expert Meeting 3 European Journal of Clinical Nutrition 2015;69:
12 Health & Nutrition Nutrition Economics Overall population Diseased population (= patients) General nutrition Medical nutrition Conventional food Survival, energy, health, pleasure Enteral nutrition Special enteral medical nutrition for all ages Functional food Infant formula/food Targets specific body functions/risk factors Age specific needs Parenteral nutrition Special parenteral (intravenous) medical nutrition for all ages Expert Meetings 1 & 2 Expert Meeting 3 British Journal of Nutrition 2011;105: British Journal of Nutrition 2013;108: European Journal of Clinical Nutrition 2015;69:
13
14 DEPARTEMENT PHARMACEUTICAL SCIENCES 14 November 2018 Challenges & Complexities in Nutrition Economics IRENE LENOIR-WIJNKOOP
15 Challenges & Complexities in Nutrition Economics The integral role that food and nutrients play in the disease etiology and progression puts a heavy burden on healthcare expenditures and should prompt decisionmakers to consider the cost and value of nutrition interventions ILW 11 November 2018
16 Common conditions of ill health British Journal of Nutrition Extension of nutritional strategies for managing civilization diseases would considerably reduce healthcare expenditures ILW 11 November 2018
17 Common conditions of ill health British Journal of Nutrition Extension of nutritional strategies for managing civilization diseases would considerably reduce healthcare expenditures ILW 11 November 2018
18 Diet, Nutrition and the prevention of chronic diseases Although nutrient deficiency diseases are still prevalent in some countries, and are an important cause of ill-health and premature death, nutrient-associated chronic diseases due to incorrect balance or an excess of nutrients are now of significant importance in virtually all countries, developing and developed alike. Factors needed for successful nutrition and food policies: Food and nutrition policies must have the credibility provided by scientific and epidemiological evidence, have political and technical support, and be regarded as necessary and convenient by the consumer [citizen]. ILW 11 November 2018
19 Highly interconnected physiological & metabolic processes related to nutrients intake Frontiers Endocrinology 2018 ILW 11 November 2018
20 ILW 11 November 2018
21 OECD Data. Health resources - Health spending. ILW 11 November 2018
22 Conclusion In spite of an increasing number of nutritional strategies, the burden of nutrition-related illness gets skyrocketing Most health assessors do still not have nutrition on their radar, it is time to get off the beaten track of the 20th century (Medical) nutrition is essential to nourrish sustainable health care systems ILW 11 November 2018
23 Announcement
24 DISCLAIMER The information in this presentation has been compiled with the utmost care, but no rights can be derived from its contents. Utrecht University
25 The tough pathway to reimbursement for Medical Nutrition interventions Moreno Perugini Head Medical Affairs and Market Access, Nestle Health Science November 2018
26 Increasing evidence on the health outcome of Medical Nutrition Interventions Patient perspectives on nutrition,
27 Malnutrition is a big issue for the HealthCare system 30
28 Major hurdles need to be address to ensure the patient has access to medical nutrition Clinical development Regulatory framework 31
29 Regulatory framework in the US: the need to demonstrate Distinctive Nutritional Requirement Pregnancy is not a condition for which a medical food could be labeled and marketed given the requirement of DNR can be managed by modification of the diet alone. Generally the levels of micronutrients necessary for pregnancy can be achieved by the modification the normal diet alone (1) Medical Food cannot be sold for diabetes because diet therapy is the mainstay of diabetes management and that a regular diet can be modified to meet the needs of an individual affected by Diabetes Mellitus (along with appropriate drug therapy if necessary) (2) 32 (1) Draft guidance for Industry. Frequently Asked Questions about medical food 2 nd edition (2013). Question #24 (2) Draft guidance for Industry. Frequently Asked Questions about medical food 2 nd edition (2013). Question #26
30 Major hurdles need to be address to ensure the patient has access to medical nutrition Clinical development Regulatory framework Coverage policy 33
31 Coverage policy in the US Medicare: NCD Enteral and parenteral therapy (1) limits the coverage to beneficiaries Who have a permanent functional impairment of the GI tract Who require tube feeding to maintain weight and strength, and For whom enteral nutrition is reasonable and necessary Commercial coverage landscape for CD (2) Commercial plans: The situation varies plan by plan but on average most of the plans recall Medicare determination for coverage 34(1) CMS National Coverage Determination NCD for Enteral and Parenteral Nutritional Therapy (2) Extrapolation of coverage distribution from sampled regional payers to all regional commercial payers. Focus on oral medical food coverage for Crohn s disease. Quorum consulting 2014
32 35 Since the product is oral it will not be reimbursed by Medicare
33 Coverage policy in EU Different provisions market by market Most of the markets do not follow drug reimbursement pathway Provisions usually include nutritionally complete Medical Nutrition interventions that are sole source of nutrition Reimbursement criteria based on specific compositional criteria according to local regulation 36
34 Major hurdles need to be address to ensure the patient has access to medical nutrition Clinical development Incentives for innovation Regulatory framework Coverage policy 37
35 Which incentives for innovation? Different methodologies exist but in general for NCE : Price of a drug is correlated to the health outcomes that the product has demonstrated, within available budget For Medical Nutrition Interventions price is generally defined by: Common lines of reimbursement By units of ingredients (e.g. protein, energy level, fibers, etc.) By calories count 38
36 Is calories count the best way to reward health outcome? Phenylketonuria (PKU) is an inborn error of metabolism that results in decreased metabolism of the amino acid phenylalanine PRODUCT COMPARISON EXPLICATIVE PRODUCT A Unit PRODUCT B Unit Daily Consumption (units) 4 Packet 0.5 Tub Perspective of the costs for one adult PKU patient requiring 60g of protein equivalent /day Calculations assume a reimbursement rate of $4/100 calories from Payer to Provider Product A and Product B deliver the same amount of Protein Equivalent Monthly Consumption (g) 3000 g 6000 g Calories / Day 296 Cals 820 Cals Daily Cost to Payer ($11.84) ($32.80) Monthly Cost to Payer ($355.20) ($984.00) Monthly Cost to Provider $ $ Monthly Reimbursement to Provider $ $ Provider Net Profit ($344.80) $
37 Major hurdles need to be address to ensure the patient has access to medical nutrition Clinical development Incentives for Innovation Regulatory framework Coverage policy 40
38 Debate view points 1. Can the rise of medical foods tackle unsustainable public healthcare costs? 2. How should reimbursement policies evolve? What is needed to have (medical) nutrition valued as a health care intervention? - Awareness? - Knowledge? - Evidence? - Stakeholders? - Frameworks?
39
Health Economics & Nutrition Economics
Health Economics & Nutrition Economics Cost & cost effectiveness nutrition therapy Karen Freijer, PhD, BSc 30 September 2017 k.freyer@maastrichtuniversity.nl Chair ISPOR Nutrition Economics SIG http://www.ispor.org/sigs/nutritionecon
More informationImpact of Nutrition on Public Health
Impact of Nutrition on Public Health "LET MEDICINE BE THY FOOD, AND FOOD BE THY MEDICINE. HIPPOCRATES OF COS, GREECE 460-377 B.C. Which role for HTA in NUTRITION? The important policy question is the appropriate
More informationPolitical Economy of the Medical Products Industry
Political Economy of the Medical Products Industry Tom Hazlet Survey of Biomedical Regulatory Affairs Spring 2008 Menu Definitions medical products political economy Commodities drugs devices biologics
More informationHealthy Nutrition & Life style Let us start at the beginning!
Faculty of Science Departement Pharmaceutical Sciences Healthy Nutrition & Life style Let us start at the beginning! Irene LENOIR-WIJNKOOP P.I.Lenoir-Wijnkoop@uu.nl Disclosures Director Public Health &
More informationHealth Economics & Nutri3on Economics
Health Economics & Nutri3on Economics Cost & cost effechveness nutrihon therapy Karen Freijer, PhD, BSc 30 September 2017 k.freyer@maastrichtuniversity.nl Chair ISPOR NutriHon Economics SIG hlp://www.ispor.org/sigs/
More informationOriginal Effective Date: 9/10/09
Subject: Oral and Tube Fed Enteral Nutrition Policy Number: MCR-070 *(This MCR replaces and combines MCG-070 & 071) Original Effective Date: 9/10/09 Revision Date(s): 6/29/12, 8/7/14 This MCR is no longer
More informationNATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE. Nutrition support in adults: oral supplements, enteral and parenteral feeding.
NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE 1 Guideline title SCOPE Nutrition support in adults: oral supplements, enteral and parenteral feeding. 1.1 Short title Nutrition support 2 Background a) The National
More informationProposal for an EU Joint Action on Vaccination: Cross-border challenges to be addressed
1. Background Proposal for an EU Joint Action on Vaccination: Cross-border challenges to be addressed Vaccination certainly constitutes one of the most cost-effective public health interventions implemented
More informationThe cost of the double burden of malnutrition. April Economic Commission for Latin America and the Caribbean
The cost of the double burden of malnutrition April 2017 Economic Commission for Latin America and the Caribbean What is the double burden of malnutrition? Undernutrition and obesity are often treated
More informationPolicy Statement Food for Special Medical Purposes Policy Statement
Policy Statement Food for Special Medical Purposes Policy Statement Summary The PARNUTS directive has been replaced with the Foods for Specific Groups Regulation. This seeks to ensure a consistent approach
More informationU.S. AND GLOBAL MARKETS FOR ETHICAL NUTRITION IN HEALTHCARE
U.S. AND GLOBAL MARKETS FOR ETHICAL NUTRITION IN HEALTHCARE FOD029E January 2015 Mary Anne Crandall Project Analyst ISBN: 1-62296-005-X BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215
More informationStatement Of. The National Association of Chain Drug Stores. For. U.S. House of Representatives Committee on the Budget.
Statement Of The National Association of Chain Drug Stores For U.S. House of Representatives Committee on the Budget Hearing on: 2:00 p.m. 210 Cannon House Office Building National Association of Chain
More informationStatement Of. The National Association of Chain Drug Stores. For. U.S. Senate Committee on Finance. Hearing on:
Statement Of The National Association of Chain Drug Stores For U.S. Senate Committee on Finance Hearing on: 10:00 a.m. National Association of Chain Drug Stores (NACDS) 1776 Wilson Blvd., Suite 200 Arlington,
More informationDrugs for Rare Disorders
Drugs for Rare Disorders A CASE FOR NATIONAL PHARMACARE THAT LEAVES NO ONE BEHIND Disclosures WIDOWER WHOSE SPOUSE DIED WITHOUT A DIAGNOSIS FATHER OF AN ADULT CHILD WITH A RARE DISORDER CO-FOUNDER & PRESIDENT,
More informationAbstract book. Scalpel. Scissors. Fork?
Scalpel. Scissors. Fork? Abstract book There is a new way to help treat certain diseases: Personalised medical nutrition. Back in 1866, Henri Nestlé was already reducing infant mortality with his innovative
More informationADULT ENTERAL NUTRITION PARENTERAL NUTRITION U.S. REGULATORY ENVIRONMENT THE INFANT FORMULA ACT OF The 1986 Amendments
CHAPTER ONE: INTRODUCTION... 1 STUDY GOALS AND OBJECTIVES... 1 REASONS FOR DOING THE STUDY... 1 SCOPE AND FORMAT... 1 METHODOLOGY AND INFORMATION SOURCES... 2 ANALYST CREDENTIALS... 2 RELATED BCC REPORTS...
More informationThe cost of cancer treatment
The cost of cancer treatment Lieven Annemans Ghent University Lieven.annemans@ugent.be January 2016 What s the problem? those prices are too high the budgets will explode these drugs offer survival benefit
More informationGLOBAL NUTRITION REPORT. ABSTRACT This is a summary of the recently published Global Nutrition Report prepared by an Independent Expert Group.
ABSTRACT This is a summary of the recently published Global Nutrition Report prepared by an Independent Expert Group. HERD GLOBAL NUTRITION REPORT SUMMARY REPORT SUDEEP UPRETY AND BIPUL LAMICHHANE JUNE,
More informationNestlé Health Science Overview
Nestlé Health Science Overview David Yates North America Regional Business Head Nestlé Investor Seminar Boston, June 3-4, 2014 Disclaimer This presentation contains forward looking statements which reflect
More informationHealth and. Consumers
www.openprogram.eu EU action on obesity Obesity Prevention through European Network Closing event Amsterdam 25 November 2016 Attila Balogh Health determinants and inequalities European Commission Directorate-General
More informationWFP and the Nutrition Decade
WFP and the Nutrition Decade WFP s strategic plan focuses on ending hunger and contributing to a revitalized global partnership, key components to implement and achieve the Sustainable Development Goals
More information- Description, Objectives, Operational Framework
2 1. CNCD - Overview (significance, causes, burden) 2. CDAP - Description, Objectives, Operational Framework 3. Research Findings of Study on CDAP - Research Objectives and Methodology - Limitations and
More informationView on Existing Models, Applicability and Limitations: Public Health Perspective
The European Commission s science and knowledge service Joint Research Centre View on Existing Models, Applicability and Limitations: Public Health Perspective Jan Wollgast ILSI Europe Workshop Identifying
More informationBack to the future: should we live in a post-qaly world?
Back to the future: should we live in a post-qaly world? Moderator: John Spoors, Senior Analytical Lead, NHS By Ad England Rietveld john.spoors@nhs.net RJW&partners Presenters: Andrew Walker Ad Rietveld
More informationGyan Rai, PhD 06/04/2015
* Gyan Rai, PhD 06/04/2015 Objectives: 2 1. Current Definition of Probiotics 2. Regulatory Categorization & Intended Uses 3. Probiotics & Medical Foods- How to Fit? 4. Regulatory Implications & Considerations
More informationONCOLOGY: WHEN EXPERTISE, EXPERIENCE AND DATA MATTER. KANTAR HEALTH ONCOLOGY SOLUTIONS: FOCUSED I DEDICATED I HERITAGE
CATALYSTS DRIVING SUCCESSFUL DECISIONS IN LIFE SCIENCES ONCOLOGY: WHEN EXPERTISE, EXPERIENCE AND DATA MATTER. KANTAR HEALTH ONCOLOGY SOLUTIONS: FOCUSED I DEDICATED I HERITAGE AT KANTAR HEALTH, ONCOLOGY
More informationPharmaceutical System in the UK
Pharmaceutical System in the UK David Kullman Medicines, i Pharmacy and Industry Group Department of Health PPRI Conference, Vienna 30 September 2011 Disclaimer Conflict of interest: Nothing to disclose
More informationExpanding the boundaries of nutrition Luis Cantarell
Expanding the boundaries of nutrition Luis Cantarell Nestlé Investor Seminar 30 September 2013 Disclaimer This presentation contains forward looking statements which reflect Management s current views
More informationBusiness Contributions to Setting New Research Agendas: Business Platform for Nutrition Research (BPNR)
Business Contributions to Setting New Research Agendas: Business Platform for Nutrition Research (BPNR) Purpose How can we promote more investment into public research? How can we promote improved uptake
More informationMaking Social Protection More Nutrition Sensitive: A Global Overview Harold Alderman Oct. 16, 2015
Making Social Protection More Nutrition Sensitive: A Global Overview Harold Alderman Oct. 16, 2015 Why Focus on Nutrition Sensitive Programs? The 2013 Lancet Nutrition Series estimated that scaling up
More information15050/15 JS/pm 1 DGB 3B
Council of the European Union Brussels, 7 December 2015 (OR. en) 15050/15 SAN 427 OUTCOME OF PROCEEDINGS From: General Secretariat of the Council On: 7 December 2015 To: Delegations No. prev. doc.: 14391/1/15
More informationSection 1: Nutrition Competencies and Grade Level Expectations Middle School and High School
and Nutrition Competency I: Students will know and understand the relationship between the human body, nutrition and energy balance. (A) Know the six nutrient groups and their functions: Name the key nutrients
More informationFilling Research Gaps to meet the Malnutrition Challenge : building evidences
1 Filling Research Gaps to meet the Malnutrition Challenge : building evidences 20th meeting of the EC-US Task Force on Biotechnology Research 3-4 June 2010, Barcelona Isabelle de Froidmont-Göertz Unit
More informationTRANSITIONING FROM DONOR SUPPORT FOR TB & HIV IN EUROPE
TRANSITIONING FROM DONOR SUPPORT FOR TB & HIV IN EUROPE BULGARIA: CONTRACTING NGOs FOR BETTER RESULTS 1 CONTEXT Bulgaria has been a member state of the European Union (EU) since 2007 and is currently classified
More informationOngoing review of legislation on cadmium in food in the EU: Background and current state of play
Directorate-General for Health & Ongoing review of legislation on cadmium in food in the EU: Background and current state of play - International ICCO workshop, London, 3-4 May 2012 Michael Flüh bind the
More informationThe science behind labeling issues and health claims a European perspective
2005 CSL/JIFSAN Joint Symposium on Food Safety and Nutrition: Bioactive Food Components The science behind labeling issues and health claims a European perspective Dr Michele Kellerhals Scientific and
More informationThey. amounts. 1 Harvard School of. Every Day, Medical Foods: Pharmaceuticals.
Medical Foods: Managing Diseas se through Nutrition Medical foods straddle the gap between drugs and conventional foods by targeting the nutritional deficiencies that underlie disease. Given the large
More informationSESSION 3B: IMPROVING NUTRITION THROUGH SOCIAL PROTECTION PROGRAMS
SESSION 3B: IMPROVING NUTRITION THROUGH SOCIAL PROTECTION PROGRAMS Harold Alderman Senior Research Fellow Poverty, Health, and Nutrition IFPRI Keynote Presentation Moscow, September 10 Why Focus on Nutrition
More informationNortheast Health Care Quality Foundation The QIO for Maine, New Hampshire and Vermont
The Big Picture Using the Triple Aim to Provide Affordable, Accessible, and Quality Care for Older Adults with Alzheimer s Disease and their Families October 16, 2013 This material was prepared by (NHCQF),
More informationHealth Technology Assessment
Vaccination of children with a live-attenuated, intranasal, influenza vaccine Andersohn F, Bornemann R, Damm O, Frank M, Mittendorf T, Theidel U Background Influenza is a global infectious disease of the
More informationProject LIM Lifestyle Interventions Matter
Executive Summary Project LIM Lifestyle Interventions Matter Project LIM (Lifestyles Interventions Matter) will focus on lifestyle modification to reduce the risk factors for prediabetes and ultimately
More informationRepublic of Armenia Government DECREE 29 April N
Republic of Armenia Government DECREE 29 April 2010 475-N On approving State tobacco control program of Republic of Armenia for 2010-2015 and the List of priority actions According to the 2nd article of
More informationLate Stage Oncology MCDA Criteria Implementation Results in European Countries: Ukraine Focus
Late Stage Oncology MCDA Criteria Implementation Results in European Countries: Ukraine Focus Speaker: Oresta Piniazhko, PhD Senior lecturer Danylo Halytsky Lviv National Medical University, President
More informationGuideline scope Neonatal parenteral nutrition
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Guideline scope Neonatal parenteral nutrition The Department of Health in England has asked NICE to develop a new guideline on parenteral nutrition in
More informationREFERENCE CODE GDHC282DFR PUBLICATION DATE OCTOBER 2013 BELVIQ (OBESITY) - FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC282DFR PUBLICATION DATE OCTOBER 2013 BELVIQ (OBESITY) - Executive Summary Below table provides a summary of Belviq for obesity in the nine major pharmaceutical markets during the forecast
More informationBETTER WAYS TO PAY FOR CANCER CARE Creating Win-Win-Win Approaches for Oncologists, Cancer Patients, and Payers
BETTER WAYS TO PAY FOR CANCER CARE Creating Win-Win-Win Approaches for Oncologists, Cancer Patients, and Payers Harold D. Miller President and CEO Center for Healthcare Quality and Payment Reform Physicians
More informationCancer prevention and control in the context of an integrated approach
SEVENTIETH WORLD HEALTH ASSEMBLY A70/A/CONF./9 Agenda item 15.6 25 May 2017 Cancer prevention and control in the context of an integrated approach Draft resolution proposed by Brazil, Canada, Colombia,
More informationMArch The 2014 Drug Trend Report Highlights
MArch 2015 The 2014 Drug Report Highlights Highest Increase in U.S. Drug Spend Over Past Decade In 2014, the pharmacy landscape underwent a seismic change, and the budgetary impact to healthcare payers
More informationDraft of the Rome Declaration on Nutrition
Draft of the Rome Declaration on Nutrition 1. We, Ministers and Plenipotentiaries of the Members of the World Health Organization and the Food and Agriculture Organization of the United Nations, assembled
More informationSIXTEENTH MEETING OF THE HIGH LEVEL GROUP ON NUTRITION AND PHYSICAL ACTIVITY. CHAIR: Despina Spanou. Final Minutes
SIXTEENTH MEETING OF THE HIGH LEVEL GROUP ON NUTRITION AND PHYSICAL ACTIVITY 15 th NOVEMBER 2012 10.00-16.00 VENUE: CHARLEMAGNE BUILDING [ROOM: JENKINS] CHAIR: Despina Spanou Final Minutes 1. INTRODUCTION
More informationWhat is a Special Interest Group (SIG)?
PATIENT REPORTED OUTCOMES RESEARCH SPECIAL INTEREST GROUP Open Meeting 20 th Annual European Congress November 6, 2017 Glasgow, Scotland What is a Special Interest Group (SIG)? Member-driven group interested
More informationSpeed & scale to added sugars reduction: The ambition of the European soft drinks industry
> Speed & scale to added sugars reduction: The ambition of the European soft drinks industry Gloria Gabellini, Public Policy, Government Affairs & Communications Manager EU, PepsiCo Sigrid Ligné, Director
More informationSUMMARY OF THE REPLIES
Ref. Ares(2013)36608-14/01/2013 EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Health systems and products Medicinal products authorisations, EMA Brussels, SANCO/D5/FS/ci D(2013) 27105 GENERAL
More informationEssential Medicines for Universal Health Coverage. Highlights of the report
Essential Medicines for Universal Health Coverage Highlights of the report Scope and process Prompted by the 30 th anniversary of the 1985 Nairobi Conference on the Rational Use of Drugs, to ask: 1. What
More informationPREVENTION FIRST : VACCINATION AT THE HEART OF PUBLIC HEALTH
PREVENTION FIRST : VACCINATION AT THE HEART OF PUBLIC HEALTH Vaccines Europe calls for EU leadership to develop a comprehensive EU vaccination strategy aimed to support Member States in implementing effective
More informationEvaluation of the Kajiado Nutrition Programme in Kenya. May By Lee Crawfurd and Serufuse Sekidde
Evaluation of the Kajiado Nutrition Programme in Kenya May 2012 By Lee Crawfurd and Serufuse Sekidde 1 2 Executive Summary This end-term evaluation assesses the performance of Concern Worldwide s Emergency
More informationThe Economics of Tobacco and Tobacco Taxation in Bangladesh: Abul Barkat et.al
EXECUTIVE SUMMARY 01. Increase price of cigarette and Bidi by 33% (include this in the upcoming FY 2008-09 National Budget). This will decrease use rate by 14% and 9% in short and long-run respectively;
More informationAccess to newly licensed medicines. Scottish Medicines Consortium
Access to newly licensed medicines Scottish Medicines Consortium Modifiers The Committee has previously been provided with information about why the SMC uses modifiers in its appraisal process and also
More informationTHE ROME ACCORD ICN2 zero draft political outcome document for 19 November 2014
THE ROME ACCORD ICN2 zero draft political outcome document for 19 November 2014 We,..., assembled at the Second International Conference on Nutrition, on 19-21 November 2014, to address the multiple threats
More informationDIABETES CARE DEVICES MARKET IN BRAZIL, RUSSIA, INDIA & CHINA (BRIC)
DIABETES CARE DEVICES MARKET IN BRAZIL, RUSSIA, INDIA & CHINA (BRIC) R e p o r t D e s c r i p t i o n T a b l e o f C o n t e n t s L i s t o f T a b l e s S a m p l e T a b l e s R e l a t e d R e p
More informationGLOBAL PERSPECTIVES: AN OVERVIEW OF THE GLOBAL PROTEIN LANDSCAPE CHRIS SCHMIDT SENIOR CONSUMER HEALTH ANALYST MAY 3-4, 2016
GLOBAL PERSPECTIVES: AN OVERVIEW OF THE GLOBAL PROTEIN LANDSCAPE CHRIS SCHMIDT SENIOR CONSUMER HEALTH ANALYST MAY 3-4, 2016 INTRODUCTION PROTEIN IN THE PASSPORT UNIVERSE TRENDS IN FORMULATION CONCLUSION
More informationSpecific Challenges for Orphan Drugs with Paediatric Development
Specific Challenges for Orphan Drugs with Paediatric Development Tsveta Schyns-Liharska, PhD ENRAH Member of the PDCO, EMA Representing Patients and EURORDIS Disclaimer Some of the slides in this presentation
More informationCurrent Landscape: Value Assessment Frameworks. Kimberly Westrich, MA Vice President, Health Services Research
Current Landscape: Value Assessment Frameworks Kimberly Westrich, MA Vice President, Health Services Research Updated June 2016 Background There are many aspects to the U.S. health care system, as well
More informationRegional framework for action on cancer prevention and control Executive summary
Regional Committee for the Eastern Mediterranean Sixty-fourth session Provisional agenda item 3(a) EM/RC64/3 September 2017 Regional framework for action on cancer prevention and control Executive summary
More informationRohit Malpani, Director Policy & Analysis Brussels, April 26, 2016.
Current challenges and opportunities for access to affordable medicines - a perspective from a medical humanitarian organisation Rohit Malpani, Director Policy & Analysis Brussels, April 26, 2016. Médecins
More informationJOSEFIEN VENDRIK, QUALITY MANAGER IRENE JONGENELEN, COÖRDINATOR CLINICAL SUPPLIES MANAGEMENT/ SENIOR CLINICAL STUDY MANAGER
Food for Thought JOSEFIEN VENDRIK, QUALITY MANAGER IRENE JONGENELEN, COÖRDINATOR CLINICAL SUPPLIES MANAGEMENT/ SENIOR CLINICAL STUDY MANAGER CLINOPS DAG, 12 APRIL 2018 HISTORY OF RESEARCH AND DEVELOPMENT
More informationIntensifying our efforts towards a world free of the avoidable burden of NCDs
OUTCOME DOCUMENT OF THE HIGH-LEVEL MEETING OF THE GENERAL ASSEMBLY ON THE REVIEW OF THE PROGRESS ACHIEVED IN THE PREVENTION AND CONTROL OF NON- COMMUNICABLE DISEASES Revised version dated 3 July 2014 11.50
More information2018 Edition The Current Landscape of Genetic Testing
2018 Edition The Current Landscape of Genetic Testing Market growth, reimbursement trends, challenges and opportunities November April 20182017 EXECUTIVE SUMMARY Concert Genetics is a software and managed
More informationLet s Talk about Nutrition: Communication Skills for Health Care Professionals Topic 39
Let s Talk about Nutrition: Communication Skills for Health Care Professionals Topic 39 Module 39.2. Nutrition Facts: Cost-effectiveness of Nutrition Support Prof. Maurizio Muscaritoli, MD Full Professor
More informationHarmonized Salt Iodization future policy approach to achieve the mission and vision in eliminating Iodine deficiency in Europe
Harmonized Salt Iodization future policy approach to achieve the mission and vision in eliminating Iodine deficiency in Europe Introduction Brussels, 01.11.2017 The joint WHO and UNICEF report published
More informationWHO Draft Guideline: Sugars intake for adults and children. About the NCD Alliance. Summary:
WHO Draft Guideline: Sugars intake for adults and children About the NCD Alliance The NCD Alliance is a unique civil society network of over 2,000 organizations in more than 170 countries focused on raising
More informationSan Francisco Department of Public Health
San Francisco Department of Public Health Barbara A. Garcia, MPA Director of Health City and County of San Francisco Edwin M. Lee, Mayor San Francisco Department of Public Health Policy & Procedure Detail*
More informationOfficial Journal of the European Union REGULATIONS
L 259/2 REGULATIONS COMMISSION DELEGATED REGULATION (EU) 2017/1798 of 2 June 2017 supplementing Regulation (EU) No 609/2013 of the European Parliament and of the Council as regards the specific compositional
More informationThe Nutrition (Amendment) (EU Exit) Regulations 2018
The Nutrition (Amendment) (EU Exit) Regulations 2018 A public consultation Contents Introduction... 3 Why we are consulting... 4 Nutrition and Health Claims... 6 Proposals... 6 Vitamins, minerals, and
More informationEuropean Society of Clinical Microbiology and Infectious Diseases (ESCMID) Health in Europe: A Strategic Approach
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Health in Europe: A Strategic Approach Comments by the ESCMID Executive Committee, http://www.escmid.org The European Society
More informationDraft resolution submitted by the President of the General Assembly
United Nations A/68/L.53 General Assembly Distr.: Limited 7 July 2014 Original: English Sixty-eighth session Agenda item 118 Follow-up to the outcome of the Millennium Summit Draft resolution submitted
More informationNutrition Therapy. Medical Coverage Policy Enteral/Parenteral EFFECTIVE DATE: POLICY LAST UPDATED: 11/20/2018 OVERVIEW
Medical Coverage Policy Enteral/Parenteral Nutrition Therapy EFFECTIVE DATE: 01 20 2007 POLICY LAST UPDATED: 11/20/2018 OVERVIEW This policy describes the reimbursement for enteral and parenteral nutrition
More informationRepresenting Homeopaths in Europe
The European Council for Classical Homeopathy School House, Market Place, Kenninghall, Norfolk NR16 2AH United Kingdom Telephone & Fax: (44) 1953 888163 http://www.homeopathy-ecch.org Email: ecch@homeopathy-ecch.org
More informationREAL WORLD DATA GENERATION FOR MARKET ACCESS PURPOSES. Marcin Balcerzak Research Team Lead Farenta Oy
REAL WORLD DATA GENERATION FOR MARKET ACCESS PURPOSES Marcin Balcerzak Research Team Lead Farenta Oy AGENDA Real world evidence in market access landscape: demands & requirements Case studies: Product
More informationCOVERAGE WITH EVIDENCE DEVELOPMENT
COVERAGE WITH EVIDENCE DEVELOPMENT OVERVIEW AND USE TO PROMOTE BIOMARKER DEVELOPMENT IOM National Cancer Policy Forum Sean Tunis, MD, MSc November 10, 2014 CED DEFINITION AND PURPOSE Reimbursement that
More informationEU policy on acrylamide in food reducing human exposure to ensure a high level of human health protection
Directorate-General for Health & Food Safety EU policy on acrylamide in food reducing human exposure to ensure a high level of human health protection Frans Verstraete Principles for regulating contaminants
More informationSelf-regulatory proposal from the european alcoholic beverages sectors on the provision of nutrition information and ingredients listing
Self-regulatory proposal from the european alcoholic beverages sectors on the provision of nutrition information and ingredients listing Disclaimer This common part of the proposal has been approved by
More informationPotential economic impact of probiotics in respiratory tract infections
Faculty of Science Departement Pharmaceutical Sciences Potential economic impact of probiotics in respiratory tract infections Irene LENOIR-WIJNKOOP P.I.Lenoir-Wijnkoop@uu.nl Pharmabiotics Conference Paris,
More informationPanel Value Frameworks for Cancer Therapies: Are they Useful in the Context of Canadian Health Technology Assessments and Reimbursement Decisions?
Panel Value Frameworks for Cancer Therapies: Are they Useful in the Context of Canadian Health Technology Assessments and Reimbursement Decisions? 2017 CADTH Symposium Ottawa, April, 24th, 2017 Reiner
More informationDraft First Report of The WHO Independent High-Level Commission on Non- Communicable Diseases
New Delhi 16 th May 2018 Submission from AMARDEEP India, New Delhi WHO Web-based consultation 10-16 May 2018 regarding Draft First Report of The WHO Independent High-Level Commission on Non- Communicable
More informationNew Delhi Declaration
New Delhi Declaration on High Blood Pressure Thirty-first Meeting of Ministers of Health of Countries of the WHO South-East Asia Region 10 September 2013, New Delhi, India We, the Health Ministers of
More informationSUGAR, OBESITY AND DIABETES THE OTHER GLOBAL FOOD CRISIS
Health & Life Sciences SUGAR, OBESITY AND DIABETES THE OTHER GLOBAL FOOD CRISIS A CROSS-SECTOR APPROACH TO DIET-RELATED CHRONIC DISEASE A breakfast discussion as part of Oliver Wyman s participation in
More informationJuly 7, Dockets Management Branch (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm Rockville, MD 20852
July 7, 2012 Dockets Management Branch (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 Re: Docket No. FDA 2012-N-0408: Risk Evaluation and Mitigation Strategy Assessments:
More informationPresentation Objectives
Assessment of Nutritional Status & Food insecurity Presented by Megan Christensen, MS, RD Health and Aging Policy Fellow Assistant Chief/Clinical Nutrition Manager VA Salt Lake City Health Care System
More informationArticle 1: MEDSTARTUP
Article 1: MEDSTARTUP MedStartUp is a GALIEN FOUNDATION BUSINESS FRANCE program initiative which aim to allow, encourage and reward new international partnerships between innovative French and North American
More informationPharmaceutical reimbursement in Sweden Balancing benefits and costs. Andreas Engström Health Economist Dental and Pharmaceutical Benefits Agency
Pharmaceutical reimbursement in Sweden Balancing benefits and costs Andreas Engström Health Economist Dental and Pharmaceutical Benefits Agency 1 Agenda Background - Healthcare in Sweden - Pharmaceutical
More informationPriority Medicines for Europe and the World: Setting a public health based medicines development agenda
Priority Medicines for Europe and the World: Setting a public health based medicines development agenda Warren Kaplan, Veronika Wirtz (BU School of Public Health) Aukje Mantel, Pieter Stolk (UU) Béatrice
More informationIntroduction. Rare Disease Research, Health Technology Assessment and Evidence for Reimbursement FORUM
Rare Disease Research, Health Technology Assessment and Evidence for Reimbursement FORUM ISPOR 20 th Annual European Congress, Glasgow 6 th November, 2017 Introduction Sandra Nestler-Parr Rare Access,
More informationCLASSROOM DISCUSSION QUESTIONS
CLASSROOM DISCUSSION QUESTIONS Chapter 1. How Nutrition Improves: Half a Century of Understanding and Responding to the Problem of Malnutrition 1. What are some of the fragmentations that have split the
More informationU.S. Strategic Framework on Multiple Chronic Conditions ANAND PAREKH, M.D., M.P.H.
U.S. Strategic Framework on Multiple Chronic Conditions ANAND PAREKH, M.D., M.P.H. DEPUTY ASSISTANT SECRETARY FOR HEALTH U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES JUNE 22, 2011 U.S. Challenge Prevalence
More informationThe National Vaccine Advisory Committee: Reducing Patient and Provider Barriers to Maternal Immunizations
The National Vaccine Advisory Committee: Reducing Patient and Provider Barriers to Maternal Immunizations Executive Summary Maternal immunization provides important health benefits for pregnant women and
More informationJanuary 16, Dear Administrator Verma:
Ms. Seema Verma Administrator Centers for Medicare and Medicaid Services Department of Health and Human Services Attention: CMMI New Direction P.O. Box 8011 Baltimore, MD 21244-1850 Re: (CMS-4182-P) Medicare
More informationDental Payment Innovation:
Dental Payment Innovation: Best Practices of Health Center Dental Clinics in Three States Irene V. Hilton, DDS, MPH, FACD Lyubov Slashcheva, DDS, FABSCD July 16, 2018 Objectives Understand the environment
More information